Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:38
作者
Boyaci, H
Maral, H
Turan, G
Basyigit, I
Dillioglugil, MÖ
Yildiz, F
Tugay, M
Pala, A
Erçin, C
机构
[1] Kocaeli Univ, Sch Med, Dept Pediat Surg, Kocaeli, Turkey
[2] Kocaeli Univ, Sch Med, Dept Pathol, Kocaeli, Turkey
[3] Kocaeli Univ, Sch Med, Dept Biochem, Kocaeli, Turkey
[4] Kocaeli Univ, Sch Med, Dept Chest Dis, Kocaeli, Turkey
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
10.1007/s11010-006-0640-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague-Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin+erdosteine (BLM+ERD), and saline alone (control). The BLM and BLM+ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM+ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM+ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 +/- 0.15, 0.11 +/- 0.02, and 0.087 +/- 0.03 nmol/mg protein in BLM, BLM+ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 +/- 0.06, 0.60 +/- 0.09, and 0.56 +/- 0.1 mu mol/mg protein in BLM, BLM+ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 +/- 12.4, 253.2 +/- 25.2, and 287.9 +/- 34.4 nmol/mg protein) (SOD levels were 1.42 +/- 0.12, 1.75 +/- 0.17, and 1.89 +/- 0.09 U/mg protein) in BLM, BLM+ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 49 条
[31]   REMODELING OF THE LUNG IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN THE RAT - AN IMMUNOHISTOCHEMICAL STUDY OF LAMININ, TYPE-IV COLLAGEN, AND FIBRONECTIN [J].
LAZENBY, AJ ;
CROUCH, EC ;
MCDONALD, JA ;
KUHN, C .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (01) :206-214
[32]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[33]   Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats [J].
Mata, M ;
Ruíz, A ;
Cerdá, M ;
Martinez-Losa, M ;
Cortijo, J ;
Santangelo, F ;
Serrano-Mollar, A ;
Llombart-Bosch, A ;
Morcillo, EJ .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :900-905
[34]  
MCANULTY RJ, 1995, EXP NEPHROL, V3, P96
[35]   ADMINISTRATION OF ALPHA-PROTEINASE INHIBITOR AMELIORATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN HAMSTERS [J].
NAGAI, A ;
AOSHIBA, K ;
ISHIHARA, Y ;
INANO, H ;
SAKAMOTO, K ;
YAMAGUCHI, E ;
KAGAWA, J ;
TAKIZAWA, T .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03) :651-656
[36]   Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotension II type 1 receptor antagonist [J].
Otsuka, M ;
Takahashi, H ;
Shiratori, M ;
Chiba, H ;
Abe, S .
THORAX, 2004, 59 (01) :31-37
[37]   Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin [J].
Oury, TD ;
Thakker, K ;
Menache, M ;
Chang, LY ;
Crapo, JD ;
Day, BJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (02) :164-169
[38]   In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats [J].
Serrano-Mollar, A ;
Closa, D ;
Prats, N ;
Blesa, S ;
Martinez-Losa, M ;
Cortijo, J ;
Estrela, JM ;
Morcillo, EJ ;
Bulbena, O .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (06) :1037-1048
[39]   Bleomycin-induced pneumonitis [J].
Sleijfer, S .
CHEST, 2001, 120 (02) :617-+
[40]   Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats [J].
Sogut, S ;
Ozyurt, H ;
Armutcu, F ;
Kart, L ;
Iraz, M ;
Akyol, O ;
Ozen, S ;
Kaplan, S ;
Temel, I ;
Yildirim, Z .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) :213-220